Research Article

You have full text access to this OnlineOpen article

Danazol therapy for aplastic anemia refractory to immunosuppressive therapy

  1. Tatsuya Chuhjo1,
  2. Hirohito Yamazaki2,
  3. Mitsuhiro Omine3,
  4. Shinji Nakao2,*

Article first published online: 27 DEC 2007

DOI: 10.1002/ajh.21118

Issue

American Journal of Hematology

American Journal of Hematology

Volume 83, Issue 5, pages 387–389, May 2008

Additional Information

How to Cite

Chuhjo, T., Yamazaki, H., Omine, M. and Nakao, S. (2008), Danazol therapy for aplastic anemia refractory to immunosuppressive therapy. Am. J. Hematol., 83: 387–389. doi: 10.1002/ajh.21118

Author Information

  1. 1

    Department of Internal Medicine, NTT Kanazawa Hospital, Kanazawa, Ishikawa, Japan

  2. 2

    Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan

  3. 3

    Division of Hematology, Internal Medicine, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan

*Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa, Ishikawa 920-8641, Japan

Publication History

  1. Issue published online: 16 APR 2008
  2. Article first published online: 27 DEC 2007
  3. Manuscript Accepted: 31 OCT 2007
  4. Manuscript Revised: 29 OCT 2007
  5. Manuscript Received: 4 MAR 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (67K)

References

  • 1
    Madanes AE,Farber M. Danazol. Ann Intern Med 1982; 141: 453–463.
  • 2
    Beutler B,Krochin N,Milsark W, et al. Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance. Science 1986; 232: 977–980.
  • 3
    Kern JA,Lamb RJ,Reed JC, et al. Dexamethasone inhibition of interleukin 1 beta production by human monocytes. J Clin Invest 1988; 81: 237–244.
  • 4
    Mori H,Nakagawa M,Itoh N, et al. Danazol suppresses the production of interleukin-1 beta and tumor necrosis factor by human monocytes. Am J Reprod Immunol 1990; 24: 45–50.
  • 5
    Ahn YS,Harrington WJ,Simon SR, et al. Danazol for treatment of idiopathic thrombocytopenic purpura. N Engl J Med 1983; 308: 1396–1399.
  • 6
    Ahn YS. Efficacy of danazol in hematologic disorders. Acta Haematol 1990; 84: 122–129.
  • 7
    Ahn YS,Harrington WJ,Mylvaganam R, et al. Danazol therapy for autoimmune hemolytic anemia. Ann Intern Med 1985; 102: 298–301.
  • 8
    Ahn YS,Rocha R,Harrington WJ. Long-term danazol therapy in autoimmune thrombocytopenia (abstract). Blood 1989; 74: 110.
  • 9
    Cervera H,Jara LJ,Pizarro S, et al. Danazol for systemic lupus erythematosus with refractory autoimmune thrombocytopenia or Evans' syndrome. J Rheumatol 1995; 22: 1867–1871.
  • 10
    Lippman SM,Durie BGM,Garewal HS, et al. Efficacy of danazol in pure red cell aplasia. Am J Hematol 1986; 23: 373–379.
    Direct Link:
  • 11
    Najean Y,Pecking A,Danvic ML. Androgen therapy of aplastic anaemia—A prospective study of 352 cases. Scand J Haematol 1979; 22: 343–356.
    Direct Link:
  • 12
    Najean Y. Long-term follow-up in patients with aplastic anemia, a study of 137 androgen-treated patients surviving more than two years. Am J Med 1981; 71: 543–551.
  • 13
    Bacigalupo A,Chaple M,Hows J, et al. Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: A randomized trial from the EBMT SAA working party. Br J Haematol 1993; 83: 145–151.
    Direct Link:
  • 14
    Sugimori C,Chuhjo T,Feng X, et al. Minor population of CD55-CD59 blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood 2006; 107: 1308–1314.
  • 15
    Nakao S,Takamatsu H,Chuhjo T, et al. Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia. Blood. 1994; 84: 4257–4261.
  • 16
    Buzaid AC,Garewal HS,Lippman SM, et al. Danazol in the treatment of myelodysplastic syndromes. Eur J Haematol 1987; 39: 346–348.
    Direct Link:
  • 17
    Stadtmauer EA,Cassileth PA,Edelstein M, et al. Danazol treatment of myelodysplastic syndromes. Br J Haematol 1991; 77: 502–508.
    Direct Link:
  • 18
    Chan G,DiVenuti G,Miller K. Danazol for the treatment of thrombocytopenia in patients with myelodysplastic syndrome. Am J Hematol 2002; 71: 166–171.
    Direct Link:
  • 19
    Camitta BM. What is the definition of cure for aplastic anemia? Acta Haematol 2000; 103: 16–18.
Get PDF (67K)